As the GRO-α receptor CXCR2 is expressed in all bladder cancer cells irrespective of the mesenchymal phenotype, it is probable that secretion of GRO-α is associated with bladder cancer recurrence via an autocrine loop involving its receptor. The gene discussed is CXCL1; the disease is urinary bladder cancer.